全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Neurocognitive Disorders and HIV/AIDS: A Review of the Literature

DOI: 10.4236/oalib.1107308, PP. 1-7

Subject Areas: Public Health, HIV

Keywords: ARVs, NCDs, Neuropsychological Tests, Elderly PHAs, Predominantly Female

Full-Text   Cite this paper   Add to My Lib

Abstract

Background and aim: Since the discovery of ARVs, HIV/AIDS has become a chronic disease with the corollary of the aging of person living with HIV (PLHIV). This paradoxical aging is unfortunately accompanied by neurocognitive disorders (NCDs), which can be detected by the clinic and neuropsychological tests. The aim of this study is to assess the prevalence of NCDs before and after the era of antiretrovirals (ARVs). Methods: A retrospective study compared the prevalences of NCDs before and after the era of ARVs. Socio-demographic characteristics, stages of disease, prevalence of NCDs, and neurological and psychiatric disorders were the parameters of interest. Results: Age and sex: 34 ± 9 years, sex ratio 1H: 1F versus 47.4 ± 10.2 years, sex ratio 3F: 1H Depression: 23% - 29% at Stages I and II before ARVs NCDs: 11.4% (severe NCDs 8.7%) (light NCDs 2.7%) versus 75% (66% light NCDs, 8% moderate NCDs, 1% severe NCDs). Conclusion: The combination of the clinic and neuropsychological testing showed a clear progression of mild and moderate neurocognitive disorders in older and older, predominantly female PHAs, both asymptomatic and symptomatic on antiretroviral drugs.

Cite this paper

Mussa, R. M. , Mananga, G. L. , Tshala, D. K. , Toko, K. L. and Aliocha, N. (2021). Neurocognitive Disorders and HIV/AIDS: A Review of the Literature. Open Access Library Journal, 8, e7308. doi: http://dx.doi.org/10.4236/oalib.1107308.

References

[1]  Lescure, F.X. and Moulignier, A. (2014) Troubles neurocognitifs associés à l’infection VIH. Journal des Anti-Infectieux, 16, 67-73.
[2]  Bacchus, J. (1998) HIV and Older Adult. Journal Genrant Nursing, 24, 41-46.
[3]  Saylor, D., Dickens, A.M., Sackder, N., et al. (2014) HIV Associated Neurocognitive Disorder Pathogenesis and Protects for Treatment. Nature Reviews Neurology, 11, 17-051-B-10.
[4]  Kevin , V., Melani, M., Oury, C., et al. (2017) Evolution de la plateforme neuro-VIH d'un h?pital universitaire par les patients et les médecins traitants. Revue Médicale Suisse, 13, 782-786.
[5]  Muilu, J., Mananga, L.G. and Mampunza, M.S. (2017) Evaluation de la qualité de vie des personnes vivant avec le VIH/SIDA: Sous antirétroviraux à Kinshasa. Edition Universitaires Européennes, Mauritius, 31.
[6]  Bumoko, M.M., Mussa, M., Sombo, M.T., Itakala, B., Lelo, M., Bukasa, K., et al. (2016) Habileté cognitive et fonctionnement quotidien des sujets sous thérapies antirétrovirale de l’infection au VIH. Annals of African Medicine, 10, 2451.
[7]  Dauchey, F.A., Amieva, H, Collin, C., et al. (2009) Troubles cognitifs chez les personnes infectées par le VIH. Prévalence et facteurs associés au sein de la cohorte ANDS Cos Agnitaine. Analyse intermédiaire Inserm U 897, COR VIH ISPED, Université Victor Segalen Bordeaux 2: CHU Bordeaux, France, 2007-2209.
[8]  Lemogne, C., Cole, P., Consoli, S.M. and Limosin, F. (2018) Psychiatric de Liaison. Lavoisier, Paris, 436.
[9]  N’Galy, B., Mann, J.M., Columbers, R.L., et al. (1987) Séroprévalence HIV au sein d’une population des patients neuropsychiatriques à Kinshasa, Zaire. Annales de la Société Belge de Médecine Tropicale, 67, 291-294.
[10]  Mussa, M., Guy, D., Kazadi, K., et al. (1989) Les manifestations neuropsychiatriques du SIDA, Etude clinique à propos de 44 cas observés au CNPP/Mont-Amba à KinshasaAf. African Journal of Neurological Sciences, 8, 8-11.
[11]  Perrieus, J.H., Mussa, M., Luabeya, M.K., Kayembe, K., Kapita, B., Brown, C., et al. (1992) Neurological Complications of HIV-1 Seropositive Internal Medicine Patients in Kinshasa Zaire. Journal of Acquired Immune Deficiency Syndromes, 5, 333-340.
[12]  Luabeya, M.K., Tshiaka, K., Mussa, M. and Kayembe, N.T. (1994) Profil Syndromique des manifestations neuropsychiatriques du SIDA à Kinshasa/Zaire. African Journal of Neurological Sciences, 13, 17-19.
[13]  Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D’Elia, L., Sughondhabirom, B., et al. (1994) Who Neuropsychiatric AIDS Study: Cross Sectional Phase II. Neuropsychological and Neurological Findings. Archives of General Psychiatry, 51, 51-60. https://doi.org/10.1001/archpsyc.1994.03950010051007
[14]  Mussa, M., Preux, P.M., Debrock, C., et al. (1997) Syndrome cognitif et mode associés au VIH. Cahier Santé, 7, 187-193.
[15]  Swedish International Development Cooperation Agency (1998) Prévention et lutte. Sommet modial des ministres de la Santé sur les programmes et prévention du SIDA. Swedish International Development Cooperation Agency, Stockhlom, 6-7.
[16]  Girard, P.M., Kadama, C.H. and Pialoux, G. (2004) VIH. Edition, 6ème Edition, Vol. 4, Girad, Malmaison, 5-11.
[17]  Carter, M.W., Marie Kraft, J., Koppenhaver, T., Galavotti, C., Roels, T.H., Kilmarx, P.H. and Fidzani, B. (2007) “A Bull Cannot Be Contained in a Simple Kraal”: Concurrent Sexual Partnership in Botswana. AIDS and Behavior, 11, 822-839. https://doi.org/10.1007/s10461-006-9203-6
[18]  Levy, M.R. and Bredesen, D.E. (1998) Central Nervous Dysfunction in Acquired Immunodeficiency Syndrome. Journal of Acquired Immune Deficiency Syndromes, 1, 41-64.
[19]  Gray, F., Belec, L., Geny, C., et al. (1993) Diagnostic des encéphalopathies diffuses de l’adulte au cours de l’infection à Vih (1ère partie). Presse Médicale, 22, 1226-1231.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413